Which Follow-Up therapy works best for tough breast cancers?
NCT ID NCT07540520
First seen Apr 23, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This study looks at 2,000 women with HER2-positive breast cancer who still had cancer after initial treatment and surgery. Researchers compare two different drug combinations given after surgery to see which one helps prevent the cancer from coming back over three years. The goal is to find the best follow-up treatment for these patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.